Keywords
Last Name
Institution

Julie Magarian Blander

TitleASSOCIATE PROFESSOR
InstitutionMount Sinai
DepartmentClinical Immunology
Address

     Bibliographic 
     selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Shan M, Gentile M, Yeiser JR, Walland AC, Bornstein VU, Chen K, He B, Cassis L, Bigas A, Cols M, Comerma L, Huang B, Blander JM, Xiong H, Mayer L, Berin C, Augenlicht LH, Velcich A, Cerutti A. Mucus enhances gut homeostasis and oral tolerance by delivering immunoregulatory signals. Science. 2013 Oct 25; 342(6157):447-53.
      View in: PubMed
    2. Mourao-Sa D, Roy S, Blander JM. Vita-PAMPs: signatures of microbial viability. Adv Exp Med Biol. 2013; 785:1-8.
      View in: PubMed
    3. Blander JM. Designing a type I interferon signaling phagosome. Immunity. 2012 Dec 14; 37(6):947-9.
      View in: PubMed
    4. Blander JM, Torchinsky MB, Campisi L. Revisiting the old link between infection and autoimmune disease with commensals and T helper 17 cells. Immunol Res. 2012 Dec; 54(1-3):50-68.
      View in: PubMed
    5. Agudo J, Ruzo A, Kitur K, Sachidanandam R, Blander JM, Brown BD. A TLR and non-TLR mediated innate response to lentiviruses restricts hepatocyte entry and can be ameliorated by pharmacological blockade. Mol Ther. 2012 Dec; 20(12):2257-67.
      View in: PubMed
    6. Blander JM, Sander LE. Beyond pattern recognition: five immune checkpoints for scaling the microbial threat. Nat Rev Immunol. 2012 Mar; 12(3):215-25.
      View in: PubMed
    7. Garaude J, Kent A, van Rooijen N, Blander JM. Simultaneous targeting of toll- and nod-like receptors induces effective tumor-specific immune responses. Sci Transl Med. 2012 Feb 8; 4(120):120ra16.
      View in: PubMed
    8. Nair P, Amsen D, Blander JM. Co-ordination of incoming and outgoing traffic in antigen-presenting cells by pattern recognition receptors and T cells. Traffic. 2011 Dec; 12(12):1669-76.
      View in: PubMed
    9. Sander LE, Davis MJ, Boekschoten MV, Amsen D, Dascher CC, Ryffel B, Swanson JA, Müller M, Blander JM. Detection of prokaryotic mRNA signifies microbial viability and promotes immunity. Nature. 2011 Jun 16; 474(7351):385-9.
      View in: PubMed
    10. Brereton CF, Blander JM. The unexpected link between infection-induced apoptosis and a TH17 immune response. J Leukoc Biol. 2011 Apr; 89(4):565-76.
      View in: PubMed
    11. Garaude J, Blander JM. ICOStomizing immunotherapies with T(H)17. Sci Transl Med. 2010 Oct 27; 2(55):55ps52.
      View in: PubMed
    12. Brereton CF, Blander JM. Responding to infection and apoptosis--a task for TH17 cells. Ann N Y Acad Sci. 2010 Oct; 1209:56-67.
      View in: PubMed
    13. Sander LE, Sackett SD, Dierssen U, Beraza N, Linke RP, Müller M, Blander JM, Tacke F, Trautwein C. Hepatic acute-phase proteins control innate immune responses during infection by promoting myeloid-derived suppressor cell function. J Exp Med. 2010 Jul 5; 207(7):1453-64.
      View in: PubMed
    14. Mosoian A, Teixeira A, Burns CS, Sander LE, Gusella GL, He C, Blander JM, Klotman P, Klotman ME. Prothymosin-alpha inhibits HIV-1 via Toll-like receptor 4-mediated type I interferon induction. Proc Natl Acad Sci U S A. 2010 Jun 1; 107(22):10178-83.
      View in: PubMed
    15. Torchinsky MB, Garaude J, Blander JM. Infection and apoptosis as a combined inflammatory trigger. Curr Opin Immunol. 2010 Feb; 22(1):55-62.
      View in: PubMed
    16. Torchinsky MB, Blander JM. T helper 17 cells: discovery, function, and physiological trigger. Cell Mol Life Sci. 2010 May; 67(9):1407-21.
      View in: PubMed
    17. Sander LE, Blander JM. Innate immune cells cast an eye on DNA. J Mol Cell Biol. 2009 Dec; 1(2):77-9.
      View in: PubMed
    18. Blander JM, Amsen D. Immunology. Amino acid addiction. Science. 2009 Jun 5; 324(5932):1282-3.
      View in: PubMed
    19. Sander LE, Blander JM. Inflammasome and toll-like receptor 9: Partners in crime in toxic liver injury. Hepatology. 2009 Jun; 49(6):2119-21.
      View in: PubMed
    20. Torchinsky MB, Garaude J, Martin AP, Blander JM. Innate immune recognition of infected apoptotic cells directs T(H)17 cell differentiation. Nature. 2009 Mar 5; 458(7234):78-82.
      View in: PubMed
    21. Blander JM. Analysis of the TLR/NF-kappaB pathway in antigen-presenting cells in malignancies promoted by inflammation. Methods Mol Biol. 2009; 512:99-117.
      View in: PubMed
    22. Blander JM. Phagocytosis and antigen presentation: a partnership initiated by Toll-like receptors. Ann Rheum Dis. 2008 Dec; 67 Suppl 3:iii44-9.
      View in: PubMed
    23. Blander JM. Signalling and phagocytosis in the orchestration of host defence. Cell Microbiol. 2007 Feb; 9(2):290-9.
      View in: PubMed
    24. Blander JM. Coupling Toll-like receptor signaling with phagocytosis: potentiation of antigen presentation. Trends Immunol. 2007 Jan; 28(1):19-25.
      View in: PubMed
    25. Blander JM, Medzhitov R. On regulation of phagosome maturation and antigen presentation. Nat Immunol. 2006 Oct; 7(10):1029-35.
      View in: PubMed
    Blander's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts
    _
    Co-Authors
    _
    Similar People
    _
    Same Department
     
    Mount Sinai Profiles is managed by Conduits - The Institutes for Translational Sciences at Icahn School of Medicine, supported by the National Center for Research Resources and the National Center for Advancing Translational Sciences of the National Institutes of Health through Grant Number UL1TR000067